Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Medtronic
Federal Trade Commission
Chubb
Johnson and Johnson
Argus Health
McKinsey
Colorcon
Daiichi Sankyo

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070650

« Back to Dashboard

NDA 070650 describes ZAXOPAM, which is a drug marketed by Quantum Pharmics and is included in three NDAs. Additional details are available on the ZAXOPAM profile page.

The generic ingredient in ZAXOPAM is oxazepam. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxazepam profile page.
Summary for 070650
Tradename:ZAXOPAM
Applicant:Quantum Pharmics
Ingredient:oxazepam
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 070650

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength10MG
Approval Date:Mar 1, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Argus Health
Moodys
US Army
Harvard Business School
AstraZeneca
Cantor Fitzgerald
Queensland Health
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.